In vitro activities of 3-hydroxy-1,5,6-trimethoxy-2-methyl-9,10-anthraquinone against non-small cell lung carcinoma Full Text
Archives of Pharmacal Research, 08/17/2012
Clinical Article
Feng SX et al. – This preliminary study suggests that natural compound PCON6 has relatively selective cytotoxicity against NSCLC growth and represent a concept of developing a novel drug therapy specific for non–small cell lung carcinoma (NSCLC) based on the roots of C. connata or PCON6.



